|
CZ206195A3
(en)
|
1993-02-12 |
1996-04-17 |
Univ Leland Stanford Junior |
Controlled transcription of target genes and other biological materials
|
|
ATE544776T1
(de)
|
1994-12-29 |
2012-02-15 |
Massachusetts Inst Technology |
Chimäre dna-bindeproteine
|
|
KR19990022651A
(ko)
|
1995-06-07 |
1999-03-25 |
데이비드 엘. 버스테인 |
생물학적 사건에 대한 라파마이신 기재 조절방법
|
|
US6884879B1
(en)
|
1997-04-07 |
2005-04-26 |
Genentech, Inc. |
Anti-VEGF antibodies
|
|
US6117680A
(en)
|
1997-08-26 |
2000-09-12 |
Ariad Gene Therapeutics, Inc. |
Compositions and methods for regulation of transcription
|
|
CA2303482A1
(en)
|
1997-08-27 |
1999-03-04 |
Ariad Gene Therapeutics, Inc. |
Chimeric transcriptional activators and compositions and uses related thereto
|
|
CA2318402A1
(en)
|
1998-01-15 |
1999-07-22 |
Ariad Gene Therapeutics, Inc. |
Regulation of biological events using multimeric chimeric proteins
|
|
AU766513B2
(en)
|
1998-02-13 |
2003-10-16 |
Board Of Trustees Of The Leland Stanford Junior University |
Novel dimerizing agents, their production and use
|
|
PT1916258E
(pt)
|
1999-08-09 |
2014-07-29 |
Genzyme Corp |
Aumento da expressão de uma sequência nucleotídica heteróloga de cadeia simples a partir de vectores virais recombinantes por concepção da sequência de maneira que esta forme pares de bases intracadeia
|
|
US7067526B1
(en)
|
1999-08-24 |
2006-06-27 |
Ariad Gene Therapeutics, Inc. |
28-epirapalogs
|
|
BR0014945A
(pt)
|
1999-10-21 |
2004-08-31 |
Monsanto Co |
Modificação pós-traducional de proteìnas recombinantes produzidas em plantas
|
|
GB2362884A
(en)
|
2000-05-30 |
2001-12-05 |
Isis Innovation |
Extended duration of airway gene therapy
|
|
KR20030074588A
(ko)
|
2000-07-26 |
2003-09-19 |
루드빅 인스티튜트 포 캔서 리서치 |
글리코실화 ｖｅｇｆ-ｂ 및 가용성 ｖｅｇｆ-ｂ 의 양을증가시키는 방법
|
|
NZ532635A
(en)
|
2001-11-13 |
2007-05-31 |
Univ Pennsylvania |
A method of identifying unknown adeno-associated virus (AAV) sequences and a kit for the method
|
|
DK2359869T3
(en)
|
2001-12-17 |
2019-04-15 |
Univ Pennsylvania |
Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
|
|
EP1573002A4
(en)
|
2002-02-11 |
2008-07-16 |
Genentech Inc |
ANTIBODY VARIANTS WITH FASTER ANTIGEN ASSOCIATION SPEEDS
|
|
US20040208847A1
(en)
|
2003-03-28 |
2004-10-21 |
Fabienne Rolling |
Method and vectors for selectively transducing retinal pigment epithelium cells
|
|
CN1856576B
(zh)
|
2003-09-30 |
2011-05-04 |
宾夕法尼亚州立大学托管会 |
腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用
|
|
WO2006110689A2
(en)
|
2005-04-07 |
2006-10-19 |
The Trustees Of The University Of Pennsylvania |
Method of increasing the function of an aav vector
|
|
EP1777906A1
(en)
|
2005-06-09 |
2007-04-25 |
Matsushita Electric Industrial Co., Ltd. |
Amplitude error compensating apparatus and orthogonality error compensating apparatus
|
|
CN101889025B
(zh)
|
2007-10-30 |
2013-11-13 |
健泰科生物技术公司 |
通过阳离子交换层析进行的抗体纯化
|
|
TWI580694B
(zh)
|
2007-11-30 |
2017-05-01 |
建南德克公司 |
抗-ｖｅｇｆ抗體
|
|
KR101010352B1
(ko)
|
2008-05-30 |
2011-01-25 |
삼성중공업 주식회사 |
전력 제어 장치 및 방법
|
|
DK2356270T3
(da)
|
2008-11-07 |
2016-12-12 |
Fabrus Llc |
Kombinatoriske antistofbiblioteker og anvendelser deraf
|
|
WO2010138263A2
(en)
|
2009-05-28 |
2010-12-02 |
University Of Massachusetts |
Novel aav 's and uses thereof
|
|
PE20120622A1
(es)
|
2009-06-17 |
2012-05-26 |
Abbott Biotherapeutics Corp |
Anticuerpos anti-vegf y sus usos
|
|
US8628966B2
(en)
|
2010-04-30 |
2014-01-14 |
City Of Hope |
CD34-derived recombinant adeno-associated vectors for stem cell transduction and systemic therapeutic gene transfer
|
|
US8927514B2
(en)
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
|
US8663624B2
(en)
|
2010-10-06 |
2014-03-04 |
The Regents Of The University Of California |
Adeno-associated virus virions with variant capsid and methods of use thereof
|
|
EP2634253B1
(en)
|
2010-10-27 |
2016-05-11 |
Jichi Medical University |
Adeno-associated virus virions for transferring genes into neural cells
|
|
WO2012109570A1
(en)
|
2011-02-10 |
2012-08-16 |
The University Of North Carolina At Chapel Hill |
Viral vectors with modified transduction profiles and methods of making and using the same
|
|
HRP20171334T1
(hr)
|
2011-04-22 |
2017-11-17 |
The Regents Of The University Of California |
Virioni adeno-povezanog virusa s kapsid varijantom i postupci njihove upotrebe
|
|
EP2559443A1
(en)
|
2011-08-16 |
2013-02-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of an ocular disease in a subject
|
|
ES2857773T5
(es)
|
2011-08-24 |
2024-06-04 |
Univ Leland Stanford Junior |
Nuevas proteínas de la cápside de AAV para la transferencia de ácidos nucleicos
|
|
US20130090375A1
(en)
|
2011-10-06 |
2013-04-11 |
Cornell University |
Virus-mediated delivery of bevacizumab for therapeutic applications
|
|
WO2013170078A1
(en)
|
2012-05-09 |
2013-11-14 |
Oregon Health & Science University |
Adeno associated virus plasmids and vectors
|
|
TWI775096B
(zh)
|
2012-05-15 |
2022-08-21 |
澳大利亞商艾佛蘭屈澳洲私營有限公司 |
使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd)
|
|
EP2916827B1
(en)
|
2012-11-08 |
2020-06-10 |
Clearside Biomedical Inc. |
Methods for the treatment of ocular disease in human subjects
|
|
US9567376B2
(en)
|
2013-02-08 |
2017-02-14 |
The Trustees Of The University Of Pennsylvania |
Enhanced AAV-mediated gene transfer for retinal therapies
|
|
EP2970946A4
(en)
|
2013-03-13 |
2016-09-07 |
Philadelphia Children Hospital |
ADENOASSOZED VIRUS VECTORS AND METHOD FOR USE THEREOF
|
|
SI2984166T1
(sl)
|
2013-03-15 |
2020-09-30 |
The Trustees Of The University Of Pennsylvania |
Sestavki za zdravljenje MPSI
|
|
US9585971B2
(en)
|
2013-09-13 |
2017-03-07 |
California Institute Of Technology |
Recombinant AAV capsid protein
|
|
HUE052676T2
(hu)
|
2013-10-11 |
2021-05-28 |
Massachusetts Eye & Ear Infirmary |
Eljárások õsi vírusszekvenciák elõrejelzésére és alkalmazásaik
|
|
CN115058452A
(zh)
|
2013-12-03 |
2022-09-16 |
霍欧奇帕生物科技有限公司 |
Cmv疫苗
|
|
GB201403684D0
(en)
|
2014-03-03 |
2014-04-16 |
King S College London |
Vector
|
|
WO2015164757A1
(en)
|
2014-04-25 |
2015-10-29 |
Oregon Health & Science University |
Methods of viral neutralizing antibody epitope mapping
|
|
ES2876409T3
(es)
|
2014-04-25 |
2021-11-12 |
Univ Pennsylvania |
Variantes del RLBD y su uso en composiciones para reducir los niveles de colesterol
|
|
PE20170261A1
(es)
|
2014-05-13 |
2017-04-12 |
Univ Pennsylvania |
Composiciones que comprenden virus adenoasociado (aav) que expresa constructos de anticuerpos duales y sus usos
|
|
WO2015191508A1
(en)
|
2014-06-09 |
2015-12-17 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
US10064752B2
(en)
|
2014-09-11 |
2018-09-04 |
Orbit Biomedical Limited |
Motorized suprachoroidal injection of therapeutic agent
|
|
CA2977355A1
(en)
|
2015-02-20 |
2016-08-25 |
University Of Iowa Research Foundation |
Methods and compositions for treating genetic eye diseases
|
|
EA201792500A1
(ru)
|
2015-05-13 |
2018-04-30 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Aav-опосредованная экспрессия антител против гриппа и способы их использования
|
|
AU2016315703A1
(en)
|
2015-08-31 |
2018-03-08 |
The Trustees Of The University Of Pennsylvania |
Chimeric AAV-anti-VEGF for treating cancer in canines
|
|
GB201519086D0
(en)
|
2015-10-28 |
2015-12-09 |
Syncona Partners Llp |
Gene Therapy
|
|
CN108778330A
(zh)
|
2016-01-08 |
2018-11-09 |
科尼尔赛德生物医学公司 |
用阿柏西普和其他生物制品治疗后眼部障碍的方法和装置
|
|
JP7046828B2
(ja)
|
2016-04-15 |
2022-04-04 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
滲出型加齢性黄斑変性の治療のための組成物
|
|
WO2017181021A1
(en)
|
2016-04-15 |
2017-10-19 |
Regenxbio Inc. |
Treatment of ocular diseases with fully-human post-translationally modified anti-vegf fab
|
|
SG11202002396TA
(en)
|
2017-09-27 |
2020-04-29 |
Regenxbio Inc |
Treatment of ocular diseases with fully-human post-translationally modified anti-vegf fab
|
|
EP4667578A3
(en)
|
2019-04-03 |
2026-04-01 |
REGENXBIO Inc. |
Gene therapy for eye pathologies
|